PEARW
Price:
$0.0059
Market Cap:
$4.09M
Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.
Industry
Medical - Healthcare Information Services
IPO Date
Stock Exchange
NASDAQ
Ticker
PEARW
According to Pear Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -39.23%. This represents a change of -344.12% compared to the average of 16.07% of the last 4 quarters.
The mean historical ROE of Pear Therapeutics, Inc. over the last ten years is -15.91%. The current -39.23% ROE has changed 146.56% with respect to the historical average. Over the past ten years (40 quarters), PEARW's ROE was at its highest in in the December 2022 quarter at 94.25%. The ROE was at its lowest in in the December 2021 quarter at -101.63%.
Average
-15.91%
Median
-20.60%
Minimum
-77.62%
Maximum
55.17%
Discovering the peaks and valleys of Pear Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 245.89%
Maximum Annual ROE = 55.17%
Minimum Annual Increase = -394.07%
Minimum Annual ROE = -77.62%
| Year | ROE | Change |
|---|---|---|
| 2022 | -77.62% | 245.89% |
| 2021 | -22.44% | -140.67% |
| 2020 | 55.17% | -394.07% |
The current ROE of Pear Therapeutics, Inc. (PEARW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-14.96%
5-year avg
-15.91%
10-year avg
-15.91%
Pear Therapeutics, Inc.’s ROE is less than Ra Medical Systems, Inc. (451.17%), greater than Hillstream BioPharma, Inc. (-1397.15%), greater than Altamira Therapeutics Ltd. (-111.64%), greater than Xylo Technologies Ltd. (-11.40%), greater than TNF Pharmaceuticals, Inc. (-48.34%), less than Gamida Cell Ltd. (1.15%), greater than Xylo Technologies Ltd. (-11.40%), greater than UpHealth, Inc. (-105.25%), less than Aptose Biosciences Inc. (123.88%), greater than Gritstone bio, Inc. (-124.41%),
| Company | ROE | Market cap |
|---|---|---|
| 451.17% | $3.84M | |
| -1397.15% | $4.17M | |
| -111.64% | $1.13M | |
| -11.40% | $3.77M | |
| -48.34% | $9.18M | |
| 1.15% | $4.34M | |
| -11.40% | $4.47M | |
| -105.25% | $5.33M | |
| 123.88% | $4.36M | |
| -124.41% | $3.80M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pear Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pear Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Pear Therapeutics, Inc.'s ROE?
How is the ROE calculated for Pear Therapeutics, Inc. (PEARW)?
What is the highest ROE for Pear Therapeutics, Inc. (PEARW)?
What is the 3-year average ROE for Pear Therapeutics, Inc. (PEARW)?
What is the 5-year average ROE for Pear Therapeutics, Inc. (PEARW)?
How does the current ROE for Pear Therapeutics, Inc. (PEARW) compare to its historical average?